PEG-MGF vs MGF China Wholesale Buyer Guide

Create two independent molecular specifications

Write separate RFQ lines for MGF and PEG-MGF with the controlled name, peptide sequence or molecular reference, form, nominal content, purity or composition criteria, quantity and Research Use Only status. For PEG-MGF, add the PEG specification rather than treating the prefix as a generic long-acting label. Require the supplier to map each internal SKU to the quote, COA, analytical sample, vial label and packing list. Similar research-category placement and equal vial strength do not authorize substitution.

Define PEG mass and attachment chemistry

A PEG-MGF quotation should identify the PEG molecular-mass range, attachment site or strategy, linkage chemistry and expected PEG-to-peptide relationship as applicable. Ask whether the material is a defined conjugate or a distribution and how batch consistency is controlled. A supplier should explain which analytical results support the claimed construct. Without these fields, two PEG-MGF offers may represent technically different materials even when both labels say 2mg and both carry a high headline purity value.

Compare the shared 2mg label correctly

Record vial count, units per kit, total nominal target material, content tolerance, parent lot, finished lot and price basis separately for PEG-MGF and MGF. Confirm whether the 2mg statement for PEG-MGF refers to the conjugate, the peptide component, or another defined basis. The same number on two labels does not establish the same molar amount or material basis. Price comparisons must use an agreed denominator and document the calculation rather than relying on cost per vial.

Match analytical methods to each material

MGF and PEG-MGF need molecule-specific identity and purity or composition evidence. For PEG-MGF, ask how the analytical package addresses conjugation, free peptide, free PEG and distribution where relevant. Review expected molecular information, sample ID, complete chromatograms or profiles, dates, method references, specifications, results and authorization. HPLC and mass spectrometry can be valuable, but neither should be interpreted outside method scope. A report for unconjugated MGF cannot qualify the PEG conjugate.

Control lot genealogy and mixed-order labels

Identify the source peptide lot, PEG material or reagent record, conjugation batch, purification batch, fill batch and finished PEG-MGF lot as appropriate. Require distinct full-name labels and lot codes for PEG-MGF and MGF. For mixed shipments, obtain a segregated packing list and ask how filling-line clearance and warehouse picking prevent swaps. Receiving staff should match representative vial labels and seals to approved records and quarantine unexplained identity, strength or lot discrepancies.

Build one comparable wholesale RFQ matrix

Send every candidate the same fields: controlled identity, strength, vial count, total material, target purity or composition, identity method, quantitative-content basis, offered lot, testing status, packaging, documents, MOQ, lead time and shipping term. Mark missing answers as exceptions instead of filling gaps with assumptions. Separate testing, setup, customization and transport costs from recurring unit price. A standardized matrix gives scientific, purchasing and quality reviewers one auditable record and prevents an incomplete offer from appearing cheaper simply because it describes less work.

Apply a batch-focused quality-control review

Define every required attribute, acceptance criterion, method and record before purchase. Use the quality-control framework to connect each supplier claim to evidence and its method scope. Check sample identifiers, dates, report numbers, units and lot relationships across the complete reports. Batch-specific evidence is more decision-useful than a representative certificate. Preserve original files, record revisions and investigate contradictions before approving shipment. Where risk warrants, arrange independent testing under a documented sampling and custody plan.

Create a documentation gate before dispatch

List the required batch COA, analytical attachments, SDS, specification, supported storage statement, label proof, invoice and packing list in the RFQ and purchase order. Reconcile product, strength, lot, quantity and revision across records with the documentation guide. Require replacement documents when the offered lot changes. The importer remains responsible for current destination requirements. Research-use wording improves clarity but cannot guarantee customs entry or replace destination-specific legal and broker review.

Verify supplier and batch ownership

Document the legal seller, manufacturing site, analytical laboratory, filling or packaging site, inventory owner, release authority and dispatch entity for the exact SKU. A trading or coordination company can work with qualified partners, but roles and accountability must be transparent. Ask who owns the batch record, authorizes release, handles deviations and provides corrective action. Require advance notification when a critical party changes. Business-registration evidence supports identity but does not replace technical qualification of the offered lot.

Plan logistics and receiving controls

Confirm dispatch location, carrier, shipping term, packaging configuration and realistic production, release and transit windows. Reject guarantees of customs clearance or misleading declarations. On receipt, document package condition, seals, product, strength, lot and quantity, then connect internal inventory to the supplier batch. Store according to the applicable approved specification and quarantine unexplained damage, label conflicts, quantity differences or excursions until a documented quality decision is completed.

Use actual performance for repeat-order approval

A controlled evaluation order should use the same specification and evidence expectations planned for wholesale scale. Assess document accuracy, packaging, delivery time, communication and corrective response. Update a supplier scorecard from observed performance rather than catalog breadth or claims. For every new lot, repeat the batch review and approve current documents before dispatch. Require notification before changes to material specification, manufacturing, testing, filling, labels, packaging or other buyer-approved conditions.

Related products and same-category guides

• PEG-MGF 2mg
• MGF 2mg
• IGF-1 LR3 Supplier Guide
• HPLC and MS Testing Guide

Frequently asked questions